XML 63 R39.htm IDEA: XBRL DOCUMENT
v3.22.4

Segment Reporting and Foreign Operations (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Segment Reporting [Abstract] |
Schedule of Long-lived Assets by Geographic Area | Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2022, 2021 and 2020, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |  | 2020
United States | ​ | $ | 281,290 | ​ | $ | 275,311 | ​ | $ | 277,643
Ireland | ​ |  | 40,749 | ​ |  | 39,863 | ​ |  | 42,951
Other foreign countries | ​ |  | 60,937 | ​ |  | 56,484 | ​ |  | 62,134
Total | ​ | $ | 382,976 | ​ | $ | 371,658 | ​ | $ | 382,728
​
Schedule of Segment Reporting Information, by Segment | Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2022, 2021 and 2020, are as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 |  | 2021 |  | 2020
Net sales | ​ | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 1,118,224 | ​ | $ | 1,043,227 | ​ | $ | 934,202
Endoscopy | ​ |  | 32,757 | ​ |  | 31,524 | ​ |  | 29,673
Total net sales | ​ |  | 1,150,981 | ​ |  | 1,074,751 | ​ |  | 963,875
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income (loss) from operations | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 80,946 | ​ |  | 53,415 | ​ |  | (7,042)
Endoscopy | ​ |  | 6,617 | ​ |  | 7,501 | ​ |  | 5,480
Total income (loss) from operations | ​ |  | 87,563 | ​ |  | 60,916 | ​ |  | (1,562)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other expense — net | ​ |  | (4,934) | ​ |  | (6,999) | ​ |  | (11,669)
Income tax expense (benefit) | ​ |  | 8,113 | ​ |  | 5,463 | ​ |  | (3,388)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | 74,516 | ​ | $ | 48,454 | ​ | $ | (9,843)
Total depreciation and amortization by operating segment for the years ended December 31, 2022, 2021 and 2020, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |  | 2020
Cardiovascular | ​ | $ | 80,777 | ​ | $ | 83,000 | ​ | $ | 93,160
Endoscopy | ​ |  | 1,027 | ​ |  | 1,066 | ​ |  | 910
Total | ​ | $ | 81,804 | ​ | $ | 84,066 | ​ | $ | 94,070
​ Total capital expenditures for property and equipment by operating segment for the years ended December 31, 2022, 2021 and 2020, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |  | 2020
Cardiovascular | ​ | $ | 44,925 | ​ | $ | 27,557 | ​ | $ | 45,803
Endoscopy | ​ |  | 104 | ​ |  | 382 | ​ |  | 185
Total | ​ | $ | 45,029 | ​ | $ | 27,939 | ​ | $ | 45,988
Reconciliation of Assets from Segment to Consolidated | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 |  | 2021 |  | 2020
Net sales | ​ | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 1,118,224 | ​ | $ | 1,043,227 | ​ | $ | 934,202
Endoscopy | ​ |  | 32,757 | ​ |  | 31,524 | ​ |  | 29,673
Total net sales | ​ |  | 1,150,981 | ​ |  | 1,074,751 | ​ |  | 963,875
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income (loss) from operations | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 80,946 | ​ |  | 53,415 | ​ |  | (7,042)
Endoscopy | ​ |  | 6,617 | ​ |  | 7,501 | ​ |  | 5,480
Total income (loss) from operations | ​ |  | 87,563 | ​ |  | 60,916 | ​ |  | (1,562)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other expense — net | ​ |  | (4,934) | ​ |  | (6,999) | ​ |  | (11,669)
Income tax expense (benefit) | ​ |  | 8,113 | ​ |  | 5,463 | ​ |  | (3,388)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | 74,516 | ​ | $ | 48,454 | ​ | $ | (9,843)

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph b -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration